These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 6736637
1. The development of genetic resistance to myxomatosis in wild rabbits in Britain. Ross J, Sanders MF. J Hyg (Lond); 1984 Jun; 92(3):255-61. PubMed ID: 6736637 [Abstract] [Full Text] [Related]
2. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis. Kerr PJ, Perkins HD, Inglis B, Stagg R, McLaughlin E, Collins SV, Van Leeuwen BH. Virology; 2004 Jun 20; 324(1):117-28. PubMed ID: 15183059 [Abstract] [Full Text] [Related]
3. Changes in the virulence of myxoma virus strains in Britain. Ross J, Sanders MF. Epidemiol Infect; 1987 Feb 20; 98(1):113-7. PubMed ID: 3556434 [Abstract] [Full Text] [Related]
4. Myxoma virus in rabbits. Kerr PJ, Best SM. Rev Sci Tech; 1998 Apr 20; 17(1):256-68. PubMed ID: 9638815 [Abstract] [Full Text] [Related]
5. Innate resistance to myxomatosis in wild rabbits in England. Ross J, Sanders MF. J Hyg (Lond); 1977 Dec 20; 79(3):411-5. PubMed ID: 270526 [Abstract] [Full Text] [Related]
6. Myxomatosis: the virulence of field strains of myxoma virus in a population of wild rabbits (Oryctolagus cuniculus L.) with high resistance to myxomatosis. Edmonds JW, Nolan IF, Shepherd RC, Gocs A. J Hyg (Lond); 1975 Jun 20; 74(3):417-8. PubMed ID: 1056963 [Abstract] [Full Text] [Related]
7. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Best SM, Kerr PJ. Virology; 2000 Feb 01; 267(1):36-48. PubMed ID: 10648181 [Abstract] [Full Text] [Related]
12. [Myxomatosis: rabbits have separately developed the same mechanisms of genetic resistance in France, Australia and the United Kingdom]. Marchandeau S, Queney G, Alves JM, Carneiro M, Ferrand N. Med Sci (Paris); 2019 Feb 01; 35(8-9):611-613. PubMed ID: 31532367 [No Abstract] [Full Text] [Related]
17. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis. Cavadini P, Botti G, Barbieri I, Lavazza A, Capucci L. Vaccine; 2010 Jul 26; 28(33):5414-20. PubMed ID: 20598407 [Abstract] [Full Text] [Related]